The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement
- Author
- BARBIER, Estelle1 ; VENDRUSCOLO, Leandro F2 ; SCHULTEIS, Gery4 ; KOOB, George F2 ; HEILIG, Markus1 ; SCHLOSBURG, Joel E2 ; EDWARDS, Scott2 ; JUERGENS, Nathan1 ; PARK, Paula E2 ; MISRA, Kaushik K2 ; KEJUN CHENG3 ; RICE, Kenner C3 ; SCHANK, Jesse1
[1] Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, United States
[2] Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, United States
[3] Drug Design and Synthesis Section, Chemical Biology Research Branch, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, United States
[4] Research Service, VA San Diego Healthcare System, and Department of Anesthesiology, University of California at San Diego School of Medicine, San Diego, CA, United States - Source
Neuropsychopharmacology (New York, NY). 2013, Vol 38, Num 6, pp 976-984, 9 p ; ref : 3/4 p
- CODEN
- NEROEW
- ISSN
- 0893-133X
- Scientific domain
- Cognition; Neurology; Pharmacology drugs; Psychology, psychopathology, psychiatry
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- heroin neurokinin receptor opioids self-administration substance P
- Keyword (fr)
- Antagoniste Autoadministration Héroïne Opiacés Peptide opioïde Renforcement Récepteur biologique Récepteur tachykinine NK1 Substance P Substance toxicomanogène Neuropeptide Tachykinine
- Keyword (en)
- Antagonist Self administration Heroin Opiates Opioid peptide Reinforcement Biological receptor NK1 Tachykinin receptor Substance P Drug of abuse Neuropeptide Tachykinin
- Keyword (es)
- Antagonista Autoadministración Heroína Opiados Péptido opioide Reforzamiento Receptor biológico Receptor taquikinina NK1 Substancia P Sustancia toxicomanógena Neuropéptido Taquikinina
- Classification
- Discipline
- Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27285998
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/npp.2012.261 
https://dx.doi.org/10.1038/npp.2012.261
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/npp.2012.261\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Neuropsychopharmacology (N.Y.N.Y)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"976\";s:8:\"\u0000*\u0000epage\";s:3:\"984\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BARBIER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Estelle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"VENDRUSCOLO, Leandro F\";i:1;s:15:\"SCHULTEIS, Gery\";i:2;s:14:\"KOOB, George F\";i:3;s:14:\"HEILIG, Markus\";i:4;s:18:\"SCHLOSBURG, Joel E\";i:5;s:14:\"EDWARDS, Scott\";i:6;s:16:\"JUERGENS, Nathan\";i:7;s:13:\"PARK, Paula E\";i:8;s:16:\"MISRA, Kaushik K\";i:9;s:11:\"KEJUN CHENG\";i:10;s:14:\"RICE, Kenner C\";i:11;s:13:\"SCHANK, Jesse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/npp.2012.261\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Neuropsychopharmacology (N.Y.N.Y)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"976\";s:8:\"\u0000*\u0000epage\";s:3:\"984\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BARBIER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Estelle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"VENDRUSCOLO, Leandro F\";i:1;s:15:\"SCHULTEIS, Gery\";i:2;s:14:\"KOOB, George F\";i:3;s:14:\"HEILIG, Markus\";i:4;s:18:\"SCHLOSBURG, Joel E\";i:5;s:14:\"EDWARDS, Scott\";i:6;s:16:\"JUERGENS, Nathan\";i:7;s:13:\"PARK, Paula E\";i:8;s:16:\"MISRA, Kaushik K\";i:9;s:11:\"KEJUN CHENG\";i:10;s:14:\"RICE, Kenner C\";i:11;s:13:\"SCHANK, Jesse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/npp.2012.261\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/npp.2012.261\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Neuropsychopharmacology (N.Y.N.Y)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"976\";s:8:\"\u0000*\u0000epage\";s:3:\"984\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BARBIER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Estelle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"VENDRUSCOLO, Leandro F\";i:1;s:15:\"SCHULTEIS, Gery\";i:2;s:14:\"KOOB, George F\";i:3;s:14:\"HEILIG, Markus\";i:4;s:18:\"SCHLOSBURG, Joel E\";i:5;s:14:\"EDWARDS, Scott\";i:6;s:16:\"JUERGENS, Nathan\";i:7;s:13:\"PARK, Paula E\";i:8;s:16:\"MISRA, Kaushik K\";i:9;s:11:\"KEJUN CHENG\";i:10;s:14:\"RICE, Kenner C\";i:11;s:13:\"SCHANK, Jesse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/npp.2012.261\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Neuropsychopharmacology (N.Y.N.Y)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"976\";s:8:\"\u0000*\u0000epage\";s:3:\"984\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BARBIER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Estelle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"VENDRUSCOLO, Leandro F\";i:1;s:15:\"SCHULTEIS, Gery\";i:2;s:14:\"KOOB, George F\";i:3;s:14:\"HEILIG, Markus\";i:4;s:18:\"SCHLOSBURG, Joel E\";i:5;s:14:\"EDWARDS, Scott\";i:6;s:16:\"JUERGENS, Nathan\";i:7;s:13:\"PARK, Paula E\";i:8;s:16:\"MISRA, Kaushik K\";i:9;s:11:\"KEJUN CHENG\";i:10;s:14:\"RICE, Kenner C\";i:11;s:13:\"SCHANK, Jesse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1038\/npp.2012.261\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Neuropsychopharmacology (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Neuropsychopharmacology (N.Y.N.Y)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"976\";s:8:\"\u0000*\u0000epage\";s:3:\"984\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0893-133X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"BARBIER\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Estelle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"VENDRUSCOLO, Leandro F\";i:1;s:15:\"SCHULTEIS, Gery\";i:2;s:14:\"KOOB, George F\";i:3;s:14:\"HEILIG, Markus\";i:4;s:18:\"SCHLOSBURG, Joel E\";i:5;s:14:\"EDWARDS, Scott\";i:6;s:16:\"JUERGENS, Nathan\";i:7;s:13:\"PARK, Paula E\";i:8;s:16:\"MISRA, Kaushik K\";i:9;s:11:\"KEJUN CHENG\";i:10;s:14:\"RICE, Kenner C\";i:11;s:13:\"SCHANK, Jesse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEROEW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:65:\"The NK I Receptor Antagonist L822429 Reduces Heroin Reinforcement\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
